August 28, 2026

Newborn variants may flag childhood cancer predisposition

Targeted sequencing identified cancer-risk variants in about 7% of pediatric patients who later developed early-onset solid or brain malignancies.

MDSpire News

August 28, 2026

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

MDSpire News

July 14, 2026

Autism Spectrum Disorder Linked to Distinct Urine Metabolite Pattern

Researchers proposed a new autism spectrum disorder phenotype characterized by elevated urinary microbially derived metabolites.

MDSpire News

June 08, 2026

FDA Expands Marstacimab Indication in Hemophilia A and B

Phase 3 BASIS and BASIS KIDS data supported the expanded indication across pediatric and inhibitor-pretreated populations.

MDSpire News

May 13, 2026

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

MDSpire News

May 04, 2026

FDA Expands ASCENIV Pediatric Use

Label change follows completion of required pediatric evaluation and updates prior age restrictions for treatment eligibility.

MDSpire News

April 30, 2026

Medical Oddities: From Romance to Recall Issues

Mental health check: what patients eat, watch, love, and dream may all be in play

MDSpire News

April 29, 2026

FDA Reports Results of Nationwide Infant Formula Testing

Federal testing survey examines chemical contaminant profiles across widely used products

MDSpire News

April 22, 2026

Tzield Approval Expands to Younger Patients

First disease-modifying option available for children as young as 1 year with stage 2 type 1 diabetes

MDSpire News

April 22, 2026

Combined Clavicle Model May Improve Age Estimates

Combined approach shows higher sensitivity than traditional thresholds for classifying legal adulthood.

MDSpire News